HomeBUSINESS
BUSINESS

21 Drug Makers Expect 1.6% Increase in Sales but Decline in Profits in FY2017
(Nov.15.2017)

By Reiji Anasako

Twenty-one Japanese drug makers are likely to report an overall 1.6% increase in sales and 1.2% decline in operating profit for the fiscal year ending March 2018. Though global products have been doing well, the domestic market has been sluggish. Companies listed on the first section of the Tokyo Stock Exchange are once again expected to post the highest profits overall, but growth in sales and profits for the pharma industry will remain sluggish ...
(LOG IN FOR FULL STORY)